Ascentage Pharma Group International(HK:6855)
HK$28.10-1.08 (-3.70%)
HK:6855
Ascentage Pharma Group International financials statements
HK$28.10
At close:-1.08 (-3.70%)
Want to see HK:6855 full AI Analyst Report?
Ascentage Pharma Group International (6855) Financial Statements
5 Followers
Ascentage Pharma Group International Financial Overview
Ascentage Pharma Group International's market cap is currently ¥10.45B. The company's EPS TTM is ¥-3.89; its P/E ratio is -6.14; Ascentage Pharma Group International is estimated to report earnings on March 31, 2027, and the estimated EPS forecast is ¥-0.59. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 559.26M | ¥ 980.65M | ¥ 221.98M | ¥ 209.71M | ¥ 27.91M |
| Gross Profit | ¥ 427.35M | ¥ 951.57M | ¥ 191.44M | ¥ 187.71M | ¥ 24.58M |
| Operating Income | ¥ -1.18B | ¥ -378.80M | ¥ -891.99M | ¥ -883.41M | ¥ -933.17M |
| EBITDA | ¥ -1.09B | ¥ -285.63M | ¥ -743.61M | ¥ -820.49M | ¥ -904.84M |
| Net Income | ¥ -1.21B | ¥ -405.43M | ¥ -925.64M | ¥ -882.92M | ¥ -782.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 2.47B | ¥ 1.26B | ¥ 1.10B | ¥ 1.50B | ¥ 1.75B |
| Total Assets | ¥ 3.97B | ¥ 2.62B | ¥ 2.50B | ¥ 2.83B | ¥ 2.94B |
| Total Debt | ¥ 1.98B | ¥ 1.67B | ¥ 1.80B | ¥ 1.79B | ¥ 1.08B |
| Net Debt | ¥ -490.58M | ¥ 407.29M | ¥ 726.30M | ¥ 300.49M | ¥ -659.53M |
| Total Liabilities | ¥ 2.63B | ¥ 2.34B | ¥ 2.43B | ¥ 2.42B | ¥ 1.71B |
| Stockholders' Equity | ¥ 1.33B | ¥ 264.19M | ¥ 60.42M | ¥ 408.66M | ¥ 1.23B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -1.20B | ¥ -135.65M | ¥ -782.92M | ¥ -857.20M | ¥ -1.04B |
| Operating Cash Flow | ¥ -1.17B | ¥ -111.36M | ¥ -726.08M | ¥ -653.91M | ¥ -604.68M |
| Investing Cash Flow | ¥ -1.00B | ¥ -362.04M | ¥ 21.92M | ¥ -384.61M | ¥ -466.52M |
| Financing Cash Flow | ¥ 2.54B | ¥ 314.77M | ¥ 368.75M | ¥ 619.27M | ¥ 1.78B |
Currency in CNY
